SELLAS Life Sciences Group, Inc.
Healthcare · Biotechnology · $1.01B market cap · Ranked #267 of 1,198
Scores well above the universe median on the composite. Ranks in the 78th percentile overall.
Figures come straight from the company’s filed quarterly report and feed the six-factor model (growth, quality, and value especially). This is a summary of what was reported — research, not a recommendation, and there are no analyst estimates behind it, so it isn’t a beat-or-miss call.
The latest raw values feeding the six factors.
Every rating we’ve ever assigned SLS — append-only and hash-verified. We don’t revise or delete past calls.
7 rating changes across 72 snapshots — each with the factor shift that drove it.
The full append-only record of every call we’ve made on SLS— the accountability history mainstream sites quietly edit and we can’t — is part of Proofstock Plus.
Unlock with Plus